Talphera (TLPH) Interest Coverage Ratio Growth (1y) (2011 - 2023)
Powered by 
Analysis
Talphera (TLPH) Interest Coverage Ratio Growth (1y) (2011 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 36.43% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -532.04% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -60.78% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 176.09% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1,170.12% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -471.19% |
| Dec 31, 2022 | 218.50% |
| Sep 30, 2022 | -68.69% |
| Jun 30, 2022 | -184.00% |
| Mar 31, 2022 | -69.54% |
| Dec 31, 2021 | -42.78% |
| Sep 30, 2021 | -46.31% |
| Jun 30, 2021 | -108.12% |
| Mar 31, 2021 | 26.61% |
| Dec 31, 2020 | 32.04% |
| Sep 30, 2020 | 32.90% |
| Jun 30, 2020 | 70.67% |
| Mar 31, 2020 | 43.42% |
| Dec 31, 2019 | 24.56% |
| Sep 30, 2019 | 7.30% |
| Jun 30, 2019 | -118.92% |
| Mar 31, 2019 | -154.75% |
| Dec 31, 2018 | -120.56% |
| Sep 30, 2018 | -82.88% |
| Jun 30, 2018 | -10.88% |